STOCK TITAN

Retrieve Medical Holdings Inc - RMHI STOCK NEWS

Welcome to our dedicated page for Retrieve Medical Holdings news (Ticker: rmhi), a resource for investors and traders seeking the latest updates and insights on Retrieve Medical Holdings stock.

Retrieve Medical Holdings, Inc. (OTC Pink: RMHI) is a leading provider of innovative healthcare solutions dedicated to enhancing clinical documentation efficiency and accuracy. Through its subsidiary, Retrieve Medical, Inc., the company offers cutting-edge software solutions tailored to the evolving needs of healthcare providers, optimizing patient care delivery and operational outcomes.

The company recently expanded its portfolio by partnering with a community health system, implementing its proprietary software solution, Retrieve DxTM, within a 2-hospital campus, aiming to optimize Case Mix Index (CMI) and documentation efficiency. Retrieve's software, Retrieve Dx, streamlines comorbidity identification, leading to more accurate diagnoses in less time.

Dr. Mark Rosenberg, Chairman of Retrieve, expressed delight with the partnership, highlighting the software's ability to enhance documentation and ultimately increase revenue for hospitals. Retrieve Medical is recognized for its commitment to quality healthcare provision and operational excellence in the industry.

Rhea-AI Summary

Retrieve Medical Holdings (OTC Pink: RMHI) has emphasized its commitment to compliance amid increased scrutiny of Medicare Advantage billing practices. The company's patent-pending Retrieve Dx technology acts as a virtual research assistant, presenting potential diagnoses from patient records before physician finalization.

The announcement comes as Medicare Advantage programs, representing $462 billion (54%) of federal Medicare spending and serving 32.8 million beneficiaries across 3,500 plans, face intense scrutiny. Retrieve's preprocessing technology ensures accurate diagnosis submissions by integrating research assistant functions without disrupting clinical workflow.

Unlike systems that use AI to retroactively add diagnoses, Retrieve Dx operates prospectively, supporting accurate coding from the outset while maintaining physician control over the CDI process. The company emphasizes that its approach prevents False Claims Act violations by avoiding unsupported diagnosis additions through template addenda forms.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Retrieve Medical Holdings has signed a Letter of Intent to acquire Cúratus , a Nevada-based technology company specializing in AI-driven provider data solutions. The acquisition will integrate Cúratus' SaaS platform, ProviderLenz, into Retrieve's healthcare solutions network.

The deal is subject to definitive agreement, closing conditions, public filings, and shareholder approval. Mark Fabiano, Cúratus' CEO and former Chief Sales Officer at Altegra Health, will continue leading the company as a subsidiary of Retrieve Medical Holdings.

ProviderLenz uses AI to aggregate and verify provider credentialing and directory data in real-time, addressing a critical issue in healthcare where credentialing errors and fraud contribute to over $100 billion in annual healthcare fraud costs. The merger aims to enhance operational efficiency, improve decision-making, and optimize patient care through advanced AI capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Retrieve Medical has announced its expansion into ambulatory care through a new partnership with Saint Joseph's Medical Center in Yonkers, New York. The 333-bed health system will implement Retrieve's AI-powered software in its busiest multi-specialty physician practice.

The software has been specifically enhanced for outpatient settings, focusing on chronic condition detection and management. This implementation aligns with value-based healthcare models, aiming to improve patient outcomes and increase reimbursement potential.

According to Mark Rosenberg, Chairman of Retrieve and Past President of the American College of Emergency Physicians, chronic condition identification is important for value-based care, impacting both patient wellness and financial sustainability. Saint Joseph's Medical Center, established in 1888, continues its commitment to innovation and excellence in healthcare management through this partnership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
85.19%
Tags
none
Rhea-AI Summary

Onpoint Healthcare Partners and Retrieve Medical have announced the successful integration of their healthcare technology solution, combining Retrieve Medical's AI-powered engine with Onpoint's Iris platform. The integrated solution is being launched at two sites with over 850 healthcare providers.

The implementation aims to enhance clinical workflows, reduce administrative burdens, and improve patient outcomes. Key benefits include improved documentation efficiency with a 50% decrease in administrative overload, enhanced chronic disease management through identification and management of conditions in patient records, and reduction in provider burnout.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
Rhea-AI Summary

Retrieve Medical and OnPoint Healthcare Partners have announced a groundbreaking technology partnership to integrate Retrieve Medical's AI-powered engine into OnPoint's IRIS platform. This collaboration aims to revolutionize healthcare technology by enhancing clinical documentation and data processing capabilities.

The integration is expected to significantly improve healthcare efficiency, potentially reducing patient visit times by up to 50% and allowing physicians to manage complex disease state data more effectively. This partnership is set to address the growing administrative burden on healthcare providers, combat burnout, and improve patient care quality.

The combined technologies will excel in identifying and managing chronic conditions, providing healthcare professionals with more accurate and timely patient health insights. This advancement is poised to set new standards in healthcare technology, moving towards a more efficient and patient-centric healthcare system.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Summary

Retrieve Medical Holdings announced a new patent aimed at improving problem list management within electronic health records (EHR) systems. The patent introduces a hierarchical structure to problem lists, allowing designated managers to control and oversee entries and modifications. Key features include segmentation by department or interest area, master problem list management by primary care physicians, and individual provider lists that integrate into the master list. This innovation aims to enhance control, visibility, and accuracy in patient data management, ultimately helping healthcare providers deliver higher-quality care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Retrieve Medical has been selected to exhibit its AI-driven software, Retrieve Dx, at the Vizient Innovative Technology Exchange on Sept. 18 in Las Vegas. Retrieve Dx enhances medical documentation efficiency, providing comprehensive records for hospitals and medical centers. Vizient, the nation's largest healthcare performance improvement company, will host the event. The Exchange allows selected suppliers to demonstrate improvements in clinical outcomes, safety, and healthcare delivery. Retrieve Dx helps medical practices document essential health details, improve patient outcomes, and increase reimbursement levels by working with all major EMR applications.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Retrieve Medical Holdings, Inc. (OTC Pink: RMHI) has announced significant findings from a study on Physician Burnout, revealing a 43% decrease in physician queries over seven months. The study highlights the impact of administrative burdens on physician well-being and patient care, underscoring the importance of mitigating distractions to improve healthcare provision.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Retrieve Medical Holdings, Inc. (RMHI) announces the successful launch of Retrieve Dx™ software at two community hospitals in Louisiana, improving medical documentation accuracy and workflow efficiency. The software aims to enhance Case Mix Index (CMI), leading to better reimbursement outcomes, increased quality scores, reduced query rates, and decreased documentation time.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Retrieve Medical Holdings, Inc. (RMHI) announced a study showing a substantial increase in documented diagnoses using the Retrieve Dx software, resulting in improved physician documentation. The study analyzed 10,542 patient charts and identified 12,506 additional comorbidities and diagnoses. Retrieve Dx streamlines the validation and inclusion of comorbidities in patient records, positively impacting the Case Mix Index and reducing physician queries.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Retrieve Medical Holdings (rmhi)?

The current stock price of Retrieve Medical Holdings (rmhi) is $7 as of February 28, 2025.

What is the market cap of Retrieve Medical Holdings (rmhi)?

The market cap of Retrieve Medical Holdings (rmhi) is approximately 44.4M.

What does Retrieve Medical Holdings, Inc. specialize in?

Retrieve Medical Holdings, Inc. specializes in providing innovative healthcare solutions that enhance clinical documentation efficiency and accuracy.

What recent achievement did Retrieve Medical Holdings, Inc. announce?

Retrieve Medical Holdings, Inc. recently expanded its portfolio by partnering with a community health system and implementing its proprietary software solution, Retrieve DxTM, to optimize documentation efficiency.

Who is the Chairman of Retrieve Medical Holdings, Inc.?

Dr. Mark Rosenberg serves as the Chairman of Retrieve Medical Holdings, Inc., bringing extensive experience and expertise to the company.

How does Retrieve Medical Holdings, Inc.'s software streamline comorbidity identification?

Retrieve Medical Holdings, Inc.'s software, Retrieve Dx, streamlines comorbidity identification by presenting comorbidities to the physician's computer screen for validation and potential inclusion in the patient's record.

What impact does Retrieve Medical Holdings, Inc.'s software have on Case Mix Index (CMI)?

Retrieve Medical Holdings, Inc.'s software, Retrieve Dx, positively influences the Case Mix Index (CMI) by enhancing documentation of comorbidities and increasing the comorbidity capture rate.

How does Retrieve Medical Holdings, Inc.'s software benefit hospitals?

Retrieve Medical Holdings, Inc.'s software enables hospitals to code patients with a more comprehensive diagnosis, improving patient outcomes and increasing reimbursement levels.

What distinguishes Retrieve Medical Holdings, Inc.'s software in the healthcare industry?

Retrieve Medical Holdings, Inc.'s software seamlessly integrates with major Electronic Medical Record (EMR) Applications, making it a versatile and efficient solution for healthcare providers.

Who can benefit from Retrieve Medical Holdings, Inc.'s innovative solutions?

Healthcare providers, hospitals, Emergency Departments, and ambulatory care practices can benefit from Retrieve Medical Holdings, Inc.'s innovative software solutions.

What is the focus of Retrieve Medical Holdings, Inc.'s proprietary platform?

Retrieve Medical Holdings, Inc.'s proprietary platform focuses on empowering physicians, enhancing diagnostic accuracy, and revolutionizing the healthcare industry through advanced software solutions.

How can I learn more about Retrieve Medical Holdings, Inc.?

For additional information about Retrieve Medical Holdings, Inc., visit the company's website at www.retrievemedical.com or contact info@retrievemedical.com.
Retrieve Medical Holdings Inc

Nasdaq:RMHI

RMHI Rankings

RMHI Stock Data

44.40M
20.83M
0.87%
Shell Companies
Financial Services
United States